Sionna Therapeutics, Inc.
SION
$18.16
$0.814.67%
NASDAQ
03/31/2025 | 03/31/2024 | ||||
---|---|---|---|---|---|
Net Income | -4.00% | 0.24% | |||
Total Depreciation and Amortization | -4.79% | 3.11% | |||
Total Amortization of Deferred Charges | -- | -- | |||
Total Other Non-Cash Items | 147.12% | -10.14% | |||
Change in Net Operating Assets | -159.09% | -180.86% | |||
Cash from Operations | -38.26% | -76.80% | |||
Capital Expenditure | -218.52% | -- | |||
Sale of Property, Plant, and Equipment | -- | -- | |||
Cash Acquisitions | -- | -- | |||
Divestitures | -- | -- | |||
Other Investing Activities | -1,025.00% | -1,809.34% | |||
Cash from Investing | -1,027.20% | -1,838.59% | |||
Total Debt Issued | -- | -- | |||
Total Debt Repaid | -- | -- | |||
Issuance of Common Stock | 809,456.00% | -- | |||
Repurchase of Common Stock | -- | -- | |||
Issuance of Preferred Stock | -- | -- | |||
Repurchase of Preferred Stock | -- | -- | |||
Total Dividends Paid | -- | -- | |||
Other Financing Activities | -- | -- | |||
Cash from Financing | 14,474.22% | -- | |||
Foreign Exchange rate Adjustments | -- | -- | |||
Miscellaneous Cash Flow Adjustments | -- | -- | |||
Net Change in Cash | 2,102.40% | 13,751.54% | |||